MARKET

CAI

CAI

Caris Life Sciences, Inc.
NASDAQ
15.77
+0.21
+1.35%
Opening 12:59 07/21 EDT
OPEN
15.50
PREV CLOSE
15.56
HIGH
16.06
LOW
15.13
VOLUME
1.05M
TURNOVER
--
52 WEEK HIGH
42.50
52 WEEK LOW
14.19
MARKET CAP
4.46B
P/E (TTM)
-10.7213
1D
5D
1M
3M
1Y
5Y
1D
Caris Life Sciences: Disrupting Cancer Screening And Therapy Selection
Seeking Alpha · 10h ago
Weekly Report: what happened at CAI last week (0713-0717)?
Weekly Report · 1d ago
Caris Life Sciences (CAI) Stock Looks Undervalued Even As Caution Persists
Simply Wall St · 4d ago
Caris Life Sciences schedules second-quarter 2026 results webcast
PUBT · 5d ago
Caris Life Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026
PR Newswire · 5d ago
Caris Life Sciences price target lowered to $30 from $31 at TD Cowen
TipRanks · 6d ago
Caris Life Sciences To Offer In-House PTEN Immunohistochemistry Testing After Recent FDA Approval Of Biomarker-Guided Therapy And Diagnostic Assay
Benzinga · 07/14 12:36
Caris Life Sciences expands prostate cancer offering with PTEN IHC testing
TipRanks · 07/14 12:35
More
About CAI
Caris Life Sciences Inc. is a patient-centric, next-generation artificial intelligence tech bio company and precision medicine provider. The Company develops and commercializes solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Its entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. Its platform is purpose-built to leverage the convergence of next-generation sequencing (NGS), artificial intelligence (AI) and machine learning (ML) technologies, and high-performance computing. Its purpose-built, proprietary multi-omic profiling solutions capture and analyze molecular information from tissue and blood in a comprehensive manner. Its services for biopharma companies include prospective and retrospective profiling services, and companion diagnostics development.

Webull offers Caris Life Sciences, Inc. stock information, including NASDAQ: CAI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CAI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CAI stock methods without spending real money on the virtual paper trading platform.